自身免疫诊断十年演变:英国NEQAS室间质量评估项目的经验教训
该研究分析了2012至2021年英国NEQAS免疫学、免疫化学和过敏EQA报告,评估自身免疫诊断的协调化水平并识别改进领域。结果显示几乎所有项目的参与实验室数量增加,ELISA使用减少而新方法增加,符合预期阴性或阳性靶值的结果数量略有增加,并描述了各检测和方法最常见错误原因。
要点
- 过去十年自身抗体检测项目参与实验室增加,ELISA使用减少而化学发光、Luminex等新方法增加。
- 几乎所有自身抗体符合预期靶值的结果数量略有增加,但协调化仍面临挑战。
- 研究描述了每种特定检测和方法最常见的错误或误判原因。
核心结论
- 尽管自身抗体检测领域仍需解决诸多挑战以提高质量和协调化,但 analyzed 期间自身抗体范围扩大、新检测和方法引入及自动化平台出现带来了显著变化。
研究设计与样本
- 回顾性分析2012至2021年英国NEQAS「免疫学、免疫化学和过敏」EQA报告,涵盖多种自身抗体检测项目。
主要发现
- 几乎所有EQA项目的参与实验室数量增加。
- 固相方法中ELISA技术使用逐步减少,荧光酶免疫分析、化学发光免疫分析、Luminex和免疫印迹等新技术用户增加。
- 过去十年几乎所有抗体符合预期阴性或阳性靶值的结果数量略有增加。
- 研究提供了每种特定检测和方法最常见错误或误判原因的描述。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: External quality assessment (EQA) programs play a pivotal role in harmonizing laboratory practices, offering users a benchmark system to evaluate their own performance and identify areas requiring improvement. The objective of this study was to go through and analyze the UK NEQAS "Immunology, Immunochemistry and Allergy" EQA reports between 2012 and 2021 to assess the overall level of harmonization in autoimmune diagnostics and identify areas requiring improvement for future actions. METHODS: The EQA programs reviewed included anti-nuclear (ANA), anti-dsDNA, anti-centromere, anti-extractable nuclear antigen (ENA), anti-phospholipids, anti-neutrophil cytoplasm (ANCA), anti-proteinase 3 (PR3), anti-myeloperoxidase (MPO), anti-glomerular basement membrane (GBM), rheumatoid factor (RF), anti-citrullinated protein antibodies (ACPA), mitochondrial (AMA), liver-kidney-microsomal (LKM), smooth muscle (ASMA), APCA, and celiac disease antibodies. RESULTS: In the analyzed period, the number in participating laboratories showed an increase for almost all programs. Among solid phase methods, the use of ELISA techniques showed a progressive reduction, while new technologies, such as the fluoroenzymatic immunoassay, chemiluminescence immunoassay, Luminex and immunoblot showed an increased number of users. The number of results complying with the expected negative or positive target slightly increased for almost all antibodies in the last decade. A description of the most frequent causes of mistakes or misinterpretation for each specific test and method is also provided in this study. CONCLUSIONS: Although numerous challenges need to be addressed in the area of autoantibody detection to enhance testing quality and attain higher harmonization, the period analyzed revealed that the ever-expanding range of autoantibodies, coupled with the introduction of new tests and methodologies and the advent of automated platforms, has brought about significant changes in autoimmune diagnostics.
引用
- Garrafa E, Carbone T, Infantino M, et al. Evolution of autoimmune diagnostics over the past 10 years: lessons learned from the UK NEQAS external quality assessment EQA programs. Clin Chem Lab Med. 2025. PMID: 39781619. doi:10.1515/cclm-2024-0781
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。